Tardio Jason, President and COO of Immunic, Inc. ($IMUX), made two open market purchases of company shares totaling nearly $20,000 over the last year. His most recent buy occurred on June 5, 2025. These purchases rank 3,864th out of 4,983 individual insiders, compared to an average buy of $1.46 million across about 3.3 transactions. Tardio Jason reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 16, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Appreciation Right | 330000 | $0.00 | 330,000.0000 | 100,174,766 | 9999.99% | 0.33% |
| July 16, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Appreciation Right | 660000 | $0.00 | 660,000.0000 | 100,174,766 | 9999.99% | 0.66% |
| July 16, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Appreciation Right | 660000 | $0.00 | 660,000.0000 | 100,174,766 | 9999.99% | 0.66% |
| July 16, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Appreciation Right | 330000 | $0.00 | 330,000.0000 | 100,174,766 | 9999.99% | 0.33% |
| July 16, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Appreciation Right | 330000 | $0.00 | 330,000.0000 | 100,174,766 | 9999.99% | 0.33% |
| June 5, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | P | Common Stock | 12512 | $0.79 | 12,512.0000 | 100,174,766 | 9999.99% | 0.01% |
| June 5, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Option | 598500 | $0.00 | 598,500.0000 | 100,174,766 | 9999.99% | 0.60% |
| June 5, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Option | 595000 | $0.00 | 595,000.0000 | 100,174,766 | 9999.99% | 0.59% |
| June 5, 2025 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | P | Common Stock | 12512 | $0.79 | 12,512.0000 | 100,174,766 | 9999.99% | 0.01% |
| Dec. 4, 2024 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Option | 157500 | $0.00 | 157,500.0000 | 101,272,580 | 9999.99% | 0.16% |
| July 12, 2024 | IMMUNIC, INC. | $IMUX | Tardio Jason | President and COO | A | Stock Option | 500000 | $0.00 | 500,000.0000 | 44,320,050 | 9999.99% | 1.13% |
| Feb. 22, 2024 | Ovid Therapeutics Inc. | $OVID | Tardio Jason | Chief Operating Officer | A | Common Stock | 28125 | $0.00 | 28,125.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Ovid Therapeutics Inc. | $OVID | Tardio Jason | Chief Operating Officer | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Ovid Therapeutics Inc. | $OVID | Tardio Jason | Chief Operating Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |